Scarica l'app Stockscreener
27.04
1.05%
0.28
Dopo l'orario di chiusura:
27.03
-0.010
-0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRMY Giù?
Forum
Previsione
Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie
Harmony Biosciences: Cannabinoid Fragile X Fail Merits Rating Downgrade (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences stock price target lowered to $55 at H.C. Wainwright - Investing.com India
Mizuho Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price - MarketBeat
Mizuho Lowers Price Target for Harmony Biosciences (HRMY) to $35 - GuruFocus
HRMY Stock Down as Fragile X Syndrome Study Fails to Meet Goal - The Globe and Mail
Harmony Biosciences' ZYN002 Failure Closes Off Key Revenue Diversification Path, Deutsche Bank Says - MarketScreener
Harmony Biosciences (NASDAQ:HRMY) Reaches New 12-Month Low on Analyst Downgrade - MarketBeat
Harmony Biosciences (HRMY): Deutsche Bank Adjusts Price Target | - GuruFocus
Deutsche Bank Aktiengesellschaft Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $36.00 - MarketBeat
HRMY: HC Wainwright & Co. Lowers Price Target to $55, Maintains Buy Rating | HRMY Stock News - GuruFocus
Harmony Biosciences (NASDAQ:HRMY) Price Target Lowered to $55.00 at HC Wainwright - MarketBeat
Ruffer LLP Takes $2.72 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Mizuho Cuts Price Target on Harmony Biosciences to $35 From $50, Keeps Outperform Rating - MarketScreener
Mizuho lowers Harmony Biosciences stock price target to $35 after trial setback - Investing.com UK
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $55 at H.C. Wainwright - StreetInsider
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $35 at Mizuho - StreetInsider
Harmony Biosciences reports failure in phase 3 Fragile X trial - Investing.com India
Harmony’s ZYN002 Is Latest Drug To Flunk In Fragile X Syndrome - insights.citeline.com
Harmony Biosciences stock price target lowered to $62 at Oppenheimer - Investing.com
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $62 at Oppenheimer - StreetInsider
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday - Benzinga
Harmony Biosciences reports failure in phase 3 Fragile X trial By Investing.com - Investing.com South Africa
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study - Stocktwits
Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study - Yahoo Finance
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Down After Analyst Downgrade - MarketBeat
HRMY: Needham Adjusts Price Target While Maintaining 'Buy' Ratin - GuruFocus
Needham & Company LLC Has Lowered Expectations for Harmony Biosciences (NASDAQ:HRMY) Stock Price - MarketBeat
Harmony Biosciences (HRMY) Faces Uncertainty Following Phase 3 S - GuruFocus
Harmony Biosciences stock falls after Phase 3 trial misses endpoint - Investing.com
Harmony Biosciences provides update from its phase 3 Reconnect study of ZYN002 - MarketScreener
Harmony Biosciences (HRMY) Shares Decline After Trial Setback - GuruFocus
Harmony Biosciences (HRMY) Announces Phase 3 Trial Results for Z - GuruFocus
Harmony Bio posts trial setback for Fragile X therapy (HRMY) - Seeking Alpha
Harmony Biosciences' Phase 3 RECONNECT Study Of ZYN002 In Fragile X Syndrome Fails To Meet Goal - Nasdaq
Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial - MarketScreener
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome - Business Wire
CX Institutional Buys 129,916 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Purchases 10,900 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Strs Ohio Acquires Shares of 17,700 Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Raised to "Buy" at Wall Street Zen - MarketBeat
Can Harmony's CBD Gel Change The Treatment Landscape For Fragile X Patients? - RTTNews
Livforsakringsbolaget Skandia Omsesidigt Has $733,000 Stake in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
EV Market: What is the Moat Score of AHL.PRD2025 Technical Overview & Community Verified Watchlist Alerts - khodrobank.com
Harmony Biosciences Reports Record Revenue and Plans Expansion in CNS Treatments - MSN
Woodline Partners LP Purchases Shares of 181,824 Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
138,475 Shares in Harmony Biosciences Holdings, Inc. $HRMY Acquired by Acadian Asset Management LLC - MarketBeat
Short Covering: Will Wachovia Capital Trust IX Preferred Security benefit from government policyMarket Weekly Review & Risk Controlled Swing Alerts - khodrobank.com
Aug Analyst Calls: Whats the profit margin of Harmony Biosciences Holdings IncInsider Selling & AI Optimized Trade Strategies - خودرو بانک
UBS Maintains a Buy Rating on Harmony Biosciences Holdings (HRMY), Sets a $50 PT - Insider Monkey
Harmony Biosciences Holdings, Inc. $HRMY Shares Purchased by Jones Financial Companies Lllp - MarketBeat
12 Affordable Biotech Stocks to Invest In Now - Insider Monkey
Quarterly Recap: Can TPIC grow without dilutionQuarterly Risk Review & Capital Efficient Trading Techniques - خودرو بانک
Patterns Watch: Can Harmony Biosciences Holdings Inc. continue delivering strong returnsQuarterly Portfolio Report & Fast Moving Stock Trade Plans - khodrobank.com
Aug Weekly: What dividend growth rate does Harmony Biosciences Holdings Inc offerJuly 2025 WrapUp & Weekly Market Pulse Updates - خودرو بانک
Published on: 2025-09-16 16:24:07 - خودرو بانک
2.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):